Beyzadeoglu Clinic, Orthopaedics and Traumatology, 34728 Kadıköy, Istanbul, Turkey.
Jt Dis Relat Surg. 2021;32(1):234-238. doi: 10.5606/ehc.2021.77699. Epub 2021 Jan 6.
Tenosynovial giant cell tumor (TGCT) is a systematically benign but locally aggressive lesion arising from the synovium, tendon sheath or joint bursae. Even in athletes, soft tissue tumors may be the underlying reason or a component of posterior ankle impingement, although the most common mechanism is forceful and repetitive plantar flexion. In this article, we present a case of localized TGCT in a 15-year-old female patient presenting with symptoms of posterior ankle impingement. The preferred technique for treatment was complete local resection via posterior ankle endoscopy. The patient returned to sports at three months and no recurrence was observed on the last follow-up at the first postoperative year. Although rare, soft tissue tumors should be taken into consideration in posterior ankle impingement in athletes. Such benign soft tissue tumors in the posterior ankle can be treated safely and effectively via two-portal posterior endoscopic approach.
腱鞘巨细胞瘤（TGCT）是一种系统性良性但局部侵袭性病变，来源于滑膜、腱鞘或关节囊。即使在运动员中，软组织肿瘤也可能是导致踝关节后方撞击症的根本原因或其中一个组成部分，尽管最常见的机制是强力且反复的跖屈。在本文中，我们介绍了一例 15 岁女性患者的局部 TGCT 病例，该患者表现为踝关节后方撞击症的症状。首选的治疗方法是通过踝关节后内镜进行完全局部切除。患者在术后三个月恢复运动，在术后第一年的最后一次随访中未观察到复发。尽管罕见，但在运动员的踝关节后方撞击症中应考虑软组织肿瘤。通过双后入路内镜方法可以安全有效地治疗踝关节后方的这种良性软组织肿瘤。
